Delivery Order SPE2DB25D3202-SPE2DB25FTAVU
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,251.75 to AmerisourceBergen Drug Corp for the supply of PROMACTA 12.5 mg tablets in packages of 30 units. This competitively awarded, firm fixed-price contract carries no set-aside designation and is scheduled for completion by October 6, 2025. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. PROMACTA is a prescription medication used to treat thrombocytopenia, a...
- The Defense Logistics Agency (DLA) awarded a $27,935.76 delivery order to AmerisourceBergen Drug Corp for PROMACTA 25 mg tablets (30-count units) with a completion date of January 5, 2026. This non-competitive, firm fixed-price delivery order was issued on December 11, 2025, and will be performed at the company's corporate headquarters in Conshohocken, Pennsylvania. As a child order under a larger contract vehicle, this award leverages AmerisourceBergen's established relationship with DLA to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of PROMACTA 12.5 mg tablets in quantities of 30 units, with a contract ceiling value of $4,417.24 and an ultimate completion date of September 29, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The contract is performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate...
- The Defense Logistics Agency awarded a $4,655.10 firm fixed-price delivery order to AmerisourceBergen Drug Corp for PROMACTA 12.5 MG tablets (30-count unit of use packaging) on December 2, 2025, with a completion date of December 23, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The IDC serves as a...
- The Defense Logistics Agency awarded a delivery order valued at $12,029.63 to AmerisourceBergen Drug Corp for PROMACTA 75 mg tablets (30-count units) on July 11, 2025, with an ultimate completion date of August 1, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. PROMACTA is an immunosuppressant medication used to treat certain blood disorders,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for PROMACTA 75 mg tablets (30-count units) on July 22, 2025, with a ceiling value of $24,059.26 and firm fixed pricing. This non-set-aside, competitively awarded contract represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be delivered to the...
- The Defense Logistics Agency awarded a delivery order valued at $8,834.50 to AmerisourceBergen Drug Corp for PROMACTA 12.5 mg tablets (30-count units) on August 13, 2025, with a completion date of September 4, 2025. This firm fixed-price, competitively awarded contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. PROMACTA is a pharmaceutical treatment typically used for immune thrombocytopenia and other hematologic conditions,...
- The Defense Logistics Agency awarded a $8,834.50 delivery order to AmerisourceBergen Drug Corp for PROMACTA 12.5 mg tablets (30-count units) on September 25, 2025, with an ultimate completion date of October 17, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. PROMACTA is an immunosuppressant medication commonly prescribed to treat thrombocytopenia,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $4,418.06 to supply Promacta 25 mg tablets (30-count units) with an ultimate completion date of August 13, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $13,254.18 delivery order to AmerisourceBergen Drug Corp for PROMACTA 25 mg tablets (30-count units) on November 3, 2025, with an ultimate completion date of November 25, 2025. This firm fixed price delivery order represents a non-set-aside award issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The order...
- SPE2DB25D3202Indefinite Delivery Contract
- SPE2DB25D3202-SPE2DB25FTAVUDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of PROMACTA 25 mg tablets in unit packs of 30 tablets. This is a firm fixed-price contract with a ceiling value of $4,418.06, featuring an award date of July 1, 2025, and an ultimate completion date of July 23, 2025. The award was competitively procured without a set-aside designation. AmerisourceBergen Drug Corp will perform this contract from its corporate office location in Conshohocken, Pennsylvania, where the company is headquartered as a major pharmaceutical distributor supporting federal medical procurement needs. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime contract vehicle running through December 2026 that provides comprehensive global pharmaceutical support to military healthcare programs. The IDC encompasses a broad range of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains, enabling the company to fulfill medical supply requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. PROMACTA is an immunosuppressant medication used to treat thrombocytopenia, reflecting AmerisourceBergen Drug Corp's role as a critical vendor for specialized pharmaceutical commodities supporting military and veteran healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.4k | 7/1/25 |